Cargando…

Distinct molecular abnormalities underlie unique clinical features of essential thrombocythemia in children

Detalles Bibliográficos
Autores principales:	Fu, R, Liu, D, Cao, Z, Zhu, S, Li, H, Su, H, Zhang, L, Xue, F, Liu, X, Zhang, X, Cheng, T, Yang, R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4777775/ https://www.ncbi.nlm.nih.gov/pubmed/26118316 http://dx.doi.org/10.1038/leu.2015.167

Ejemplares similares

Essential thrombocythemia
por: Brière, Jean B
Publicado: (2007)

Alterations of Signaling Pathways in Essential Thrombocythemia with Calreticulin Mutation
por: Hui, Wuhan, et al.
Publicado: (2021)

Essential thrombocythemia: Busulphan revisited
por: Koduri, Prasad R.
Publicado: (2016)

Multilevel defects in the hematopoietic niche in essential thrombocythemia
por: Sun, Ting, et al.
Publicado: (2020)

Ruxolitinib for essential thrombocythemia?
por: Bose, Prithviraj, et al.
Publicado: (2017)

Essential Thrombocythemia Presenting as Paraneoplastic Glomerulonephritis
por: Abdulla, M. C., et al.
Publicado: (2018)

Mutations and thrombosis in essential thrombocythemia
por: Guglielmelli, Paola, et al.
Publicado: (2021)

ASXL1 mutations in Chinese patients with essential thrombocythemia
por: Nie, Yan-Bo, et al.
Publicado: (2018)

Emerging treatments for essential thrombocythemia
por: Okoli, Steven, et al.
Publicado: (2011)

Thromboembolic complication in Essential Thrombocythemia
por: Mozaheb, Zahra
Publicado: (2012)

Ruxolitinib for the Treatment of Essential Thrombocythemia
por: Gunawan, Arief, et al.
Publicado: (2018)

Essential Thrombocythemia in Children and Adolescents
por: Putti, Maria Caterina, et al.
Publicado: (2021)

P1047: REAL-WORLD SAFETY OF RUXOLITINIB IN PATIENTS WITH INTERMEDIATE OR HIGH RISK OF PRIMARY MYELOFIBROSIS, POST-POLYCYTHEMIA VERA MYELOFIBROSIS OR POST-ESSENTIAL THROMBOCYTHEMIA MYELOFIBROSIS IN CHINA
por: Xu, Z., et al.
Publicado: (2022)

Moyamoya syndrome in an adult with essential thrombocythemia
por: Lazzaro, Marc A., et al.
Publicado: (2011)

Essential thrombocythemia: Rare cause of chorea
por: Venkatesan, Eswaradass Prasanna, et al.
Publicado: (2014)

Mutant calreticulin causes essential thrombocythemia
por: Shimoda, Kazuya, et al.
Publicado: (2017)

Essential thrombocythemia treatment algorithm 2018
por: Tefferi, Ayalew, et al.
Publicado: (2018)

Retinal neovascularization in the setting of CALR-mutation positive essential thrombocythemia
por: Heydinger, Stanton P, et al.
Publicado: (2023)

Cytogenetic abnormalities in essential thrombocythemia: Clinical and molecular correlates and prognostic relevance in 809 informative cases
por: Gangat, Naseema, et al.
Publicado: (2022)

Low-Risk Essential Thrombocythemia: A Comprehensive Review
por: Robinson, Andrew J., et al.
Publicado: (2021)

Repeated Events of Acute Ischemic Stroke in a Patient with Essential Thrombocythemia
por: PAVALOIU, R.M., et al.
Publicado: (2017)

Posterior reversible encephalopathy syndrome with essential thrombocythemia: A case report
por: Zhang, Yunqiao, et al.
Publicado: (2019)

MPL-mutated essential thrombocythemia: a morphologic reappraisal
por: Szuber, Natasha, et al.
Publicado: (2018)

Development of rapidly fatal TAFRO syndrome-like features in a patient with essential thrombocythemia
por: Iizuka-Honma, Hiroko, et al.
Publicado: (2023)

Cerebral Dissecting Aneurysms in Patients with Essential Thrombocythemia
por: Baek, Jin Wook, et al.
Publicado: (2014)

Essential thrombocythemia: a rare disease in childhood
por: Beatrice, Julia Maimone, et al.
Publicado: (2013)

Recent advances in understanding myelofibrosis and essential thrombocythemia
por: Vainchenker, William, et al.
Publicado: (2016)

Thiol-disulphide Homeostasis in Essential Thrombocythemia Patients
por: Yıkılmaz, Aysun Şentürk, et al.
Publicado: (2019)

Updates in the management of polycythemia vera and essential thrombocythemia
por: Bose, Prithviraj, et al.
Publicado: (2019)

Generalized granuloma annulare associated with essential thrombocythemia
por: Polineni, Sai P., et al.
Publicado: (2020)

Essential thrombocythemia manifesting as ophthalmic artery occlusion
por: Thabsuwan, Kittipong, et al.
Publicado: (2020)

Limb gangrene: The first sign of essential thrombocythemia
por: Bolaman, Ali Zahit, et al.
Publicado: (2020)

Essential Thrombocythemia in Children: A Retrospective Study
por: Ameen, Muhammed, et al.
Publicado: (2021)

Splenic Infarct as the Presenting Manifestation of Essential Thrombocythemia
por: Khade, Shalaka, et al.
Publicado: (2022)

Focal Segmental Glomerulosclerosis Associated with Essential Thrombocythemia
por: Sugimoto, Hisashi, et al.
Publicado: (2022)

Coagulation status and determinants of possible aspirin resistance in patients with essential thrombocythemia
por: Yang, Erpeng, et al.
Publicado: (2022)

Serum erythropoietin levels in essential thrombocythemia: phenotypic and prognostic correlates
por: Szuber, Natasha, et al.
Publicado: (2018)

CALR mutational status identifies different disease subtypes of essential thrombocythemia showing distinct expression profiles
por: Zini, Roberta, et al.
Publicado: (2017)

A distinct molecular mutational profile and its clinical impact in essential thrombocythemia and primary myelofibrosis patients
por: Zaidi, Uzma, et al.
Publicado: (2020)

Distinct sequence features underlie microdeletions and gross deletions in the human genome
por: Qi, Mengling, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_enc3gm1j72ap7eaf80p9kqooag